Marketscreener, stock market website
3d6dcc774f35a997669498528baa.-_2MOTJOXpn9sAvVt1qDj5ONmgECv7XZasGYBHhXt7k.ganrcm0PCNecgjyl-yLlysrjrEtUxsOcR5CtThJnxNqjr-ILSioy86rGfA

Log In

Forgot your password ?
Or log in with
GoogleGoogle

Email Registration
Or log in with
GoogleGoogle
Log In

Forgot your password ?
Not a member ?
Email Registration
Or log in with
GoogleGoogle
  • Markets
    Equities
    Top Capitalization
    United Kingdom
    North America
    Europe
    Asia
    Middle East
    Sector Research
    Company calendar
    Equities Analysis
    Most popular
    UNICREDIT S.P.A.
    NVIDIA CORPORATION
    BOEING
    AIRBUS SE
    ALPHABET INC.
    MICROSOFT CORPORATION
    TESLA, INC.
    Indices
    Homepage
    Rankings
    Europe
    America
    Asia
    Africa
    Index Analysis
    Indexes News
    FTSE 100
    DAX
    CAC 40
    EURO STOXX 50
    S&P 500
    NASDAQ 100
    TSX COMP
    SHANGHAI COMPOSITE
    Currency / Forex
    Homepage
    Rankings
    Currency Cross Rate
    Currency Converter
    Forex Analysis
    Currencies News
    GBP / USD
    GBP / EUR
    GBP / CHF
    GBP / RUB
    GBP / SEK
    Commodities
    Homepage
    Energy
    Precious metals
    Agriculture
    Industrial Metals
    Livestock and Cattle
    GOLD
    CRUDE OIL (WTI)
    CRUDE OIL (BRENT)
    SILVER
    PLATINUM
    Cryptocurrencies
    Homepage
    Rankings
    Charts
    Analysis
    News
    Logo Crypto <span class='ml-5 txt-link txt-s1'>BITCOINBITCOIN
    Logo Crypto <span class='ml-5 txt-link txt-s1'>ETHEREUMETHEREUM
    Logo Crypto <span class='ml-5 txt-link txt-s1'>BINANCE COINBINANCE COIN
    Logo Crypto <span class='ml-5 txt-link txt-s1'>SOLANASOLANA
    Logo Crypto <span class='ml-5 txt-link txt-s1'>CARDANOCARDANO
    Logo Crypto <span class='ml-5 txt-link txt-s1'>CHAINLINKCHAINLINK
    Interest Rates
    Homepage
    Yield Curve
    Developed Nations
    Emerging Countries
    ETF
    Summary
    Screener
    Analysis
    News
  • News
    All News
    World
    United Kingdom
    Europe
    North America
    South America
    Asia
    Africa
    Middle East
    Emerging
    Companies
    All News
    Analyst Reco.
    Rumors
    IPOs
    Capital Markets Transactions
    New Contracts
    Profit Warnings
    Appointments
    Press Releases
    Security Transactions
    Earnings reports
    New markets
    New products
    Corporate strategies
    Legal risks
    Share buybacks
    Mergers and acquisitions
    Call Transcripts
    Guidance
    Indices
    Currency / Forex
    Commodities
    Cryptocurrencies
    ETF
    Interest Rates
    Economy
    Themes
    Asset Management
    Activism
    Climate and ESG
    Cybersecurity
    Geopolitics
    Central Banks
    Inflation
    Business Leaders
    Sectors
    Calendar
    Economic Calendar
    Company calendar
    All our articles
    Most Read News
    Hot News
  • Analysis
    All Analysis
    Must Read
    Equities
    Interviews
    Indices
    Currencies
    Commodities
    ETF
    Cryptocurrencies
    Stock Trading Strategies
    All
    America
    Europe
    Asia
  • Our Shows
    Shows
    Must Watch
    Satirical Cartoon
    Today's Editorial
    Crypto Recap
  • Stock Picks
    All our investments
    United States
    Europe
    Asia, Pacific
  • Portfolios
    Virtual Portfolios
    European Portfolio
    USA Portfolio
    Asian Portfolio
  • Watchlists
    My Watchlists
    Watchlists
    My previous session
    My most visited
    Most popular
    Investment Style
    Homepage
    Growth stocks
    Yield stocks
    Multibaggers
    Trend-Following Stocks
    Undervalued stocks
    ESG stocks
    Investment Themes
    Homepage
    Gold and Silver
    Let's all cycle!
    Digital Health and Telemedicine
    Israeli innovation
    Semiconductors
    Solar energy
  • Rankings
    Top Movers
    Short-Term Gainers & Losers
    Long-term Gainers & Losers
    Unusual volumes
    New Historical Highs
    New Historical Lows
    Top Fundamentals
    Fundamental Composite
    Sales growth
    Earnings Growth
    Profitability
    Finances
    Rankings Valuation
    Valuation Composite
    Capitalization
    P/E ratio
    Enterprise value
    Yield
    Price to Book (PBR)
    Free Cash Flow (FCF)
    Top Consensus
    Consensus composite
    Analyst Opinion
    Target price
    Opinion Divergences
    Estimates Revisions
    Analyst coverage
    Technical Analysis Rankings
    RSI
    GAPS
    STIM
    Daily Breakouts
    Weekly Breakouts
    Trends
    Volatility
    Top ranking ESG
    ESG MSCI
    Environment
    Social
    Governance
    Islamic Finance
    Paris Agreement
  • Screeners
    Stock Screener Home
    Investment Themes
    Luxury
    The Internet of Things
    Outdoor
    Diabetes
    The Cannabis Industry
    Robotics
    Technical Rankings
    Oversold stocks
    Overbought stocks
    Close to resistance
    Close to support
    Accumulation Phases
    Most volatile stocks
    Fundamental Rankings
    Top Investor Rating
    Top Trading Rating
    Top Consensus
    Top Growth
    Top Dividends
    Low valuations
    My Screeners
    All my stocks
    Watchlists
    Virtual Portfolios
  • Tools
    MarketScreener tools
    Stock Screener
    iPhone app
    Expert tools
    Stock Screener PRO
    Portfolio Creator
    Event Screener
    Dynamic Chart
    Company calendar
    Economic Calendar
    Currency Converter
  • Our Services
    Our subscriptions
    Our Stock Picks
    Stock Screener
    Thematic Investment Lists
    MarketScreener Portfolios
    European Portfolio
    USA Portfolio
    Asian Portfolio
  • Homepage
  • Markets
    • Equities
      • Top Capitalization
      • United Kingdom
      • North America
      • Europe
      • Asia
      • Middle East
      • Sector Research
      • Company calendar
      • Equities Analysis
      • Most popular
      • UNICREDIT S.P.A.
      • NVIDIA CORPORATION
      • BOEING
      • AIRBUS SE
      • ALPHABET INC.
      • MICROSOFT CORPORATION
      • TESLA, INC.
    • Indices
      • Homepage
      • Rankings
      • Europe
      • America
      • Asia
      • Africa
      • Index Analysis
      • Indexes News
      • FTSE 100
      • DAX
      • CAC 40
      • EURO STOXX 50
      • S&P 500
      • NASDAQ 100
      • TSX COMP
      • SHANGHAI COMPOSITE
    • Currency / Forex
      • Homepage
      • Rankings
      • Currency Cross Rate
      • Currency Converter
      • Forex Analysis
      • Currencies News
      • GBP / USD
      • GBP / EUR
      • GBP / CHF
      • GBP / RUB
      • GBP / SEK
    • Commodities
      • Homepage
      • Energy
      • Precious metals
      • Agriculture
      • Industrial Metals
      • Livestock and Cattle
      • GOLD
      • CRUDE OIL (WTI)
      • CRUDE OIL (BRENT)
      • SILVER
      • PLATINUM
    • Cryptocurrencies
      • Homepage
      • Rankings
      • Charts
      • Analysis
      • News
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>BITCOINBITCOIN
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>ETHEREUMETHEREUM
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>BINANCE COINBINANCE COIN
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>SOLANASOLANA
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>CARDANOCARDANO
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>CHAINLINKCHAINLINK
    • Interest Rates
      • Homepage
      • Yield Curve
      • Developed Nations
      • Emerging Countries
    • ETF
      • Summary
      • Screener
      • Analysis
      • News
  • News
    • All News
      • World
      • United Kingdom
      • Europe
      • North America
      • South America
      • Asia
      • Africa
      • Middle East
      • Emerging
    • Companies
      • All News
      • Analyst Reco.
      • Rumors
      • IPOs
      • Capital Markets Transactions
      • New Contracts
      • Profit Warnings
      • Appointments
      • Press Releases
      • Security Transactions
      • Earnings reports
      • New markets
      • New products
      • Corporate strategies
      • Legal risks
      • Share buybacks
      • Mergers and acquisitions
      • Call Transcripts
      • Guidance
    • Indices
    • Currency / Forex
    • Commodities
    • Cryptocurrencies
    • ETF
    • Interest Rates
    • Economy
    • Themes
      • Asset Management
      • Activism
      • Climate and ESG
      • Cybersecurity
      • Geopolitics
      • Central Banks
      • Inflation
      • Business Leaders
    • Sectors
    • Calendar
      • Economic Calendar
      • Company calendar
    • All our articles
    • Most Read News
    • Hot News
  • Analysis
    • All Analysis
    • Must Read
    • Equities
    • Interviews
    • Indices
    • Currencies
    • Commodities
    • ETF
    • Cryptocurrencies
    • Stock Trading Strategies
      • All
      • America
      • Europe
      • Asia
  • Our Shows
    • Shows
    • Must Watch
    • Satirical Cartoon
    • Today's Editorial
    • Crypto Recap
  • Stock Picks
    • All our investments
    • United States
    • Europe
    • Asia, Pacific
  • Portfolios
    • Virtual Portfolios
    • European Portfolio
    • USA Portfolio
    • Asian Portfolio
  • Watchlists
    • My Watchlists
      • Watchlists
      • My previous session
      • My most visited
      • Most popular
    • Investment Style
      • Homepage
      • Growth stocks
      • Yield stocks
      • Multibaggers
      • Trend-Following Stocks
      • Undervalued stocks
      • ESG stocks
    • Investment Themes
      • Homepage
      • Gold and Silver
      • Let's all cycle!
      • Digital Health and Telemedicine
      • Israeli innovation
      • Semiconductors
      • Solar energy
  • Rankings
    • Top Movers
      • Short-Term Gainers & Losers
      • Long-term Gainers & Losers
      • Unusual volumes
      • New Historical Highs
      • New Historical Lows
    • Top Fundamentals
      • Fundamental Composite
      • Sales growth
      • Earnings Growth
      • Profitability
      • Finances
    • Rankings Valuation
      • Valuation Composite
      • Capitalization
      • P/E ratio
      • Enterprise value
      • Yield
      • Price to Book (PBR)
      • Free Cash Flow (FCF)
    • Top Consensus
      • Consensus composite
      • Analyst Opinion
      • Target price
      • Opinion Divergences
      • Estimates Revisions
      • Analyst coverage
    • Technical Analysis Rankings
      • RSI
      • GAPS
      • STIM
      • Daily Breakouts
      • Weekly Breakouts
      • Trends
      • Volatility
    • Top ranking ESG
      • ESG MSCI
      • Environment
      • Social
      • Governance
      • Islamic Finance
      • Paris Agreement
  • Screeners
    • Stock Screener Home
    • Investment Themes
      • Luxury
      • The Internet of Things
      • Outdoor
      • Diabetes
      • The Cannabis Industry
      • Robotics
    • Technical Rankings
      • Oversold stocks
      • Overbought stocks
      • Close to resistance
      • Close to support
      • Accumulation Phases
      • Most volatile stocks
    • Fundamental Rankings
      • Top Investor Rating
      • Top Trading Rating
      • Top Consensus
      • Top Growth
      • Top Dividends
      • Low valuations
    • My Screeners
      • All my stocks
      • Watchlists
      • Virtual Portfolios
  • Tools
    • MarketScreener tools
      • Stock Screener
      • iPhone app
    • Expert tools
      • Stock Screener PRO
      • Portfolio Creator
      • Event Screener
    • Dynamic Chart
    • Company calendar
    • Economic Calendar
    • Currency Converter
  • Our Services
    • Our subscriptions
    • Our Stock Picks
    • Stock Screener
    • Thematic Investment Lists
    • MarketScreener Portfolios
      • European Portfolio
      • USA Portfolio
      • Asian Portfolio
Stock 4568DAIICHI SANKYO COMPANY, LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Daiichi Sankyo Company, Limited

Equities

4568

JP3475350009

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
07:30:00 23/06/2025 BST
5-day change 1st Jan Change
3,300.00 JPY -0.24% Intraday chart for Daiichi Sankyo Company, Limited -6.17% -24.17%
06-19 Japan's Nikkei retreats from 4-month high as US-Iran tensions weigh RE
06-19 Japan's Nikkei retreats from 4-month high as threat of US involvement in Iran conflict looms RE
Summary
Quotes
Charts
Technical Analysis Static Chart Total Return chart News Chart Sector Chart Comparison Chart Relative Strength Chart
News
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
Company
Profile Governance Share ownership Group Connections
Financials
Analysts' Forecasts Income Statement Balance Sheet Cash flow Financial Ratios Business Segments
Valuation
Valuation ratios Dividend
Consensus
Analysts' Opinion Estimates Revisions
Ratings
Calendar
Sector
Sector performance Sector valuations Sector dividends Financial comparisons Sector ratings Sector consensus Sector revisions
ETFs
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Jefferies Adjusts Daiichi Sankyo’s Price Target to 6,600 Yen From 5,600 Yen, Keeps at Buy

Published on 24/05/2024 at 10:58, updated on 24/05/2024 at 11:01

Share
LockThis article is reserved for members
Unlock the article: REGISTER NOW!
100% Free Registration
Already a customer? Log In
Share
mtnewswires logo
© MT Newswires - 2024

Latest news about Daiichi Sankyo Company, Limited

Japan's Nikkei retreats from 4-month high as US-Iran tensions weigh 06-19 RE
Japan's Nikkei retreats from 4-month high as threat of US involvement in Iran conflict looms 06-19 RE
IDeate-Prostate01 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Patients with Pretreated Metastatic Castration-Resistant Prostate Cancer 06-18 CI
Merck: Phase 3 trial in prostate cancer 06-18 CF
Merck Doses First Patient in Phase 3 Trial of Prostate Cancer Drug Candidate 06-18 MT
Health Canada Approves VANFLYTA®? in Canada Specifically for Adult Patients with Newly Diagnosed FLT3-ITD Positive AML 06-16 CI
DESTINY-Endometrial01 Phase 3 Trial Of ENHERTU® Initiated As First-Line Therapy In Patients With HER2 Expressing Primary Advanced Or Recurrent Endometrial Cancer 06-09 RE
AstraZeneca: Enhertu promising against breast cancer 06-05 CF
Trump's tariffs and threatened trade actions 06-04 RE
Trump's tariffs and threatened trade actions 06-04 RE
Daiichi Sankyo Company, Limited - Special Call 06-03
AstraZeneca says Enhertu slashes disease progression risk in cancer 06-02 AN
AstraZeneca and Daiichi Sankyo?S ENHERTU Plus Pertuzumab Showed A Median Progression-Free Survival Greater Than Three Years 06-02 CI
Daiichi Sankyo Inc. Announces Positive Results from the Destiny-Breast09 Phase 3 Trial 06-02 CI
AstraZeneca, Daiichi Sankyo's Gastric Cancer Phase 3 Trial Shows 'Statistically Significant' Improvement in Overall Survival 06-02 MT
Datroway Continues To Show Promising Tumor Responses As Part Of Combination Regimens In Patients With Early And Advanced Non-Small Cell Lung Cancer 06-01 RE
DATROWAY Continues to Show Promising Tumor Responses as Part of Combination Regimens in Patients with Early and Advanced Non-Small Cell Lung Cancer 06-01 CI
Enhertu Is A Specifically Engineered Her2 Directed Dxd Antibody Drug Conjugate Discovered by Daiichi Sankyo and Being Jointly Developed and Commercialized by Daiichi Sankyo and Astrazeneca 05-31 CI
Trump's tariffs and threatened trade actions 05-30 RE
Merck: voluntary withdrawal of a BLA in lung cancer 05-29 CF
Daiichi Sankyo and Merck Announces Patritumab Deruxtecan Biologics License Application for Patients with Previously Treated Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer Voluntary Withdraw 05-29 CI
Merck, Daiichi pull US application for 'guided missile' therapy for lung cancer 05-29 RE
Merck, Daiichi Sankyo Withdraw Application Seeking FDA Nod for ADC 05-29 DJ
Patritumab Deruxtecan Biologics License Application For Patients With Previously Treated Locally Advanced Or Metastatic Egfr-Mutated Non-Small Cell Lung Cancer Voluntarily Withdrawn 05-29 RE
Merck, Daiichi withdraw US application for 'guided missile' cancer drug 05-29 RE

Chart Daiichi Sankyo Company, Limited

Chart Daiichi Sankyo Company, Limited
4568: Dynamic Chart

Company Profile

Logo Daiichi Sankyo Company, Limited
Daiichi Sankyo Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The Company is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.
Employees
18,726
Sector
Pharmaceuticals
Calendar
07-29 - Q1 2025 Earnings Release (Projected)
More about the company

Income Statement and Estimates

More financial data

Analysis / Opinion

Daiichi Sankyo:  Voluntary withdrawal of MAA in the EU for Dato-DXd

Daiichi Sankyo: Voluntary withdrawal of MAA in the EU for Dato-DXd

December 31, 2024 at 12:23 pm

Daiichi Sankyo: Will Boost ADC Cancer Drug Production

October 11, 2024 at 04:31 pm
Daiichi Sankyo:  Will Boost ADC Cancer Drug Production
More Strategies

Ratings

Trading Rating
Investor Rating
ESG MSCI
AAA
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
3,300.00JPY
Average target price
5,841.18JPY
Spread / Average Target
+77.01%
Consensus
EPS Estimates
Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar
Indices Europe America Asia

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
More Indexes
My Watchlist
 

My lists
Rankings
 

More Top / Flop
Rankings
 

More Top / Flop

Currency / Forex

Forex

Commodities

Commodities

Cryptocurrencies

Cryptocurrencies
  1. Stock Market
  2. Equities
  3. 4568 Stock
  4. News Daiichi Sankyo Company, Limited
  5. Jefferies Adjusts Daiichi Sankyo’s Price Target to 6,600 Yen From 5,600 Yen, Keeps at Buy
Best financial portal

Best financial
portal

+951% of historicalperformance

+951% of historical
performance

More than 20 yearsat your side

More than 20 years
at your side

Trustpilot
+ 1,000,000members

+ 1,000,000
members

Quick & easycancellation

Quick & easy
cancellation

Our Expertsare here for you

Our Experts
are here for you

Download from Apple Store

OUR EXPERTS ARE HERE FOR YOU

Monday - Friday 9am-12pm / 2pm-6pm GMT + 1

Contact us
MarketScreener, Stock Market Live
Legal information | Cookie settings | About us | Copyright © 2025 Surperformance SAS. All rights reserved.
Stock quotes are provided by Factset, Morningstar and S&P Capital IQ
New Stock Screener: the preferred tool of investors who outperform the indices!
Outperform the market Now
Outperform the market Now

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States
United-States
Canada
Canada

MIDDLE EAST

Saudi Arabia
Saudi Arabia
United Arab Emirates
United Arab Emirates

EUROPE

France
France
Deutschland
Deutschland
Suisse
Suisse
Schweiz
Schweiz
Italia
Italia
Österreich
Österreich
België
België
Nederland
Nederland
España
España
Sverige
Sverige
United Kingdom
United Kingdom

APAC

Australia
Australia
India
India
Hong Kong
Hong Kong